drugset / Trial / NCT00092638

An Investigational Drug Study in Patients With Elevated Cholesterol and Coronary Heart Disease (0653-804)(COMPLETED)

NCT00092638

Phase 3 Completed 450 enrolled Organon and Co
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to investigate additional cholesterol lowering effects in patients with coronary heart disease by giving an investigational drug with a patient's current approved cholesterol lowering medication.

Timeline

Start
2003-05
Primary completion
2004-07
Completion
2004-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Ezetimibe Unknown 10 mg